Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cube Labs S.p.A (CUBE) Fair Value & Analysis

Financial Services · IT · Market cap €51.4M

CL Cube Labs S.p.A CUBE · MI
Price€2.34
Fair Value€1.91
Upside-18.4%
Quality92/100
Evidence: Low Range €1.42 – €2.84

Fair value as of: Jun 26, 2026

From 1 valuation models · updated 3 days ago

Fair value updated Jun 26, 2026 — revised from €3.98 to €1.91 (−52.0%) since Jun 24, 2026. Share price −4.9% over the past month.

Price vs Fair Value (12 months)

€2.46 €2.30 Fair Value €1.91 Jun 2025 Jun 2026

12‑month range €2.30 – €2.46 · fair‑value band €1.42 – €2.84 · the €2.34 price screens above the €1.91 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Cube Labs S.p.A (CUBE) currently trades at €2.34, while our model-based Fair Value estimate is €1.91 — implying the stock looks roughly 18.4% overvalued today. We read business quality at 92/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Net debt stands at €1.7M. Fundamentals as of Jun 26, 2026

About the company

Cube Labs S.p.A. is a venture capital firm and accelerator specializing in incubation, startup and early stage investments. It seeks to invest in the life science sector and healthcare technology. Cube Labs S.p.A. is based in Rome, Italy with additional offices in Rome, Italy and Leece, Italy.

Revenue & earnings trend

FY2020 – FY2024 · reported fiscal years

Cube Labs S.p.A reported revenue of €2.0M in FY2024 versus €912K in FY2020, a compound +21.8%/yr. Reported net income was −€731K in FY2024.

Revenue +21.8%/yr
FY20 €912K
FY21 €1.1M
FY22 €1.0M
FY23 €1.6M
FY24 €2.0M
Net income
FY20 €220K
FY21 €215K
FY22 −€73.2K
FY23 −€695K
FY24 −€731K

Open the full interactive analysis →

Similar stocks

6 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $4.20 $6.41 +53%
The Schiehallion Fund Limited MNTN $2.27 $4.54 +100%
BlackRock, Inc BLK 17,417 MXN 10,294 MXN -41%
BH Macro Limited BHMU $0.0442 $0.0900 +104%
Blackstone Inc BX $123.26 $52.88 -57%
Investor AB IVSBF $39.99 $79.98 +100%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Cube Labs S.p.A (CUBE) undervalued?
As of Jun 26, 2026, our model estimates a fair value of €1.91 versus a price of €2.34 — about −18% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CUBE?
Our 21-model fair value for Cube Labs S.p.A is €1.91 (as of Jun 26, 2026), built from audited fundamentals. The current price is €2.34.
What is the quality score of CUBE?
Cube Labs S.p.A has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of CUBE?
The net profit margin of Cube Labs S.p.A is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.